Information Provided By:
Fly News Breaks for August 7, 2015
CCRN
Aug 7, 2015 | 11:48 EDT
Cantor Fitzgerald analyst Joseph France said he believes the momentum evident in Cross Country Healthcare's Q2 results is sustainable and raised his price target on the stock to $17 from $15. The firm maintains its Buy rating on the stock.
News For CCRN From the Last 2 Days
There are no results for your query CCRN